Courtesy of Bev Baker-Ajene

Children With Disabilities Endure Long Waits For Life-Changing Medical Equipment

Some California children with serious health care problems wait more than a year for wheelchairs, bath benches, commodes, specialized crutches and other crucial medical equipment. Critics blame the delays on a confusing bureaucratic maze of private insurers and public programs.

Immigration policy protest outside courthouse

From Crib To Court: Trump Administration Summons Immigrant Infants

At least 70 infants have been ordered to appear in immigration court. Experts believe some were separated from their parents.

States Attacking ACA Would Suffer Most If Preexisting Conditions Shield Gets Axed

A coalition of Republican states has launched a legal challenge to the Affordable Care Act, including provisions requiring insurers to offer coverage to people with preexisting conditions without raising rates. An analysis shows that some of these states have the highest proportion of such residents.

Staggering Prices Slow Insurers’ Coverage Of CAR-T Cancer Therapy

Some state Medicaid programs are not paying for the procedures, and Medicare’s complicated payment rates have hospitals concerned that it will not cover all the costs.

Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk

It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.

State Prisons Fail To Offer Cure To 144,000 Inmates With Deadly Hepatitis C

A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C, a curable but potentially fatal disease, can’t get the expensive drugs they need to cure it. California lawmakers allocated $106 million in the state's new budget to treat more infected prisoners.

Facebook Live: The Marketing Plan That Fueled An Addiction Epidemic

Kaiser Health News senior correspondent Fred Schulte talks about a cache of files detailing Purdue Pharma’s early OxyContin marketing plan.

View All